Millennium Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Millennium Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-79,200	Closed	-$17.2M	–	7453
2021 Q1	$17.2M	Buy	+79,200	New	+$14.9M	0.01%	1220
2019 Q4	–	Sell	-100,000	Closed	-$11.5M	–	4814
2019 Q3	$11.5M	Buy	+100,000	New	+$15.2M	0.02%	1188
2016 Q4	–	Sell	-27,500	Closed	-$3.65M	–	3875
2016 Q3	$3.65M	Buy	+27,500	New	+$2.63M	0.01%	1553

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Millennium Management's GWPH Position: Q2 2021 in Review

Millennium Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 762,640 shares — an estimated $165M sold.

Millennium Management first reported a position in GWPH in Q3 2013 and held it in 27 quarters. The position peaked at $165M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Millennium Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Millennium Management sold 762,640 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $165M.
Millennium Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2013 and held it in 27 quarters.
Millennium Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $165M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Millennium Management's 13F filing for Q2 2021, filed 16 Aug 2021.